Page 1 | Search Results | Hematology, ASH Education Program

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Integrating patient-centered factors in the risk assessment of MDS

Rena J. Buckstein

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 373–380.

https://doi.org/10.1182/hematology.2019000041

Published: 2019

Journal Articles

Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials

Jennifer A. Woyach

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 476–481.

https://doi.org/10.1182/hematology.2019001321

Published: 2019

Journal Articles

Patient blood management as the standard of care

Michael F. Murphy, Antony Palmer

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 583–589.

https://doi.org/10.1182/hematology.2019000063

Published: 2019

Journal Articles

The role of targeted therapy in the management of patients with AML

Alexander E. Perl

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 54–65.

https://doi.org/10.1182/asheducation-2017.1.54

Published: 2017

Journal Articles

Prevention of central nervous system sequelae in sickle cell disease without evidence from randomized controlled trials: the case for a team-based learning collaborative

Michael R. DeBaun, Allison A. King

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 632–639.

https://doi.org/10.1182/asheducation-2016.1.632

Published: 2016

Journal Articles

Novel Approaches to the Treatment of Acute Myeloid Leukemia

Gail J. Roboz

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 43–50.

https://doi.org/10.1182/asheducation-2011.1.43

Published: 2011

Journal Articles

Optimal Therapy of Advanced Hodgkin Lymphoma

Ranjana Advani

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 310–316.

https://doi.org/10.1182/asheducation-2011.1.310

Published: 2011

Journal Articles

New Trends in the Standard of Care for Initial Therapy of Acute Myeloid Leukemia

Hugo F. Fernandez

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 56–61.

https://doi.org/10.1182/asheducation-2010.1.56

Published: 2010

NARROW

Integrating patient-centered factors in the risk assessment of MDS

Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials

Patient blood management as the standard of care

The role of targeted therapy in the management of patients with AML

Prevention of central nervous system sequelae in sickle cell disease without evidence from randomized controlled trials: the case for a team-based learning collaborative

Novel Approaches to the Treatment of Acute Myeloid Leukemia

Optimal Therapy of Advanced Hodgkin Lymphoma

New Trends in the Standard of Care for Initial Therapy of Acute Myeloid Leukemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only